GPR199P: A GPCR Involved in Cellular Signaling and Disease (G653160)
GPR199P: A GPCR Involved in Cellular Signaling and Disease
G protein-coupled receptors (GPCRs) are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. GPR199P, also known as GPCR 199, is a GPCR that is expressed in many tissues and cells, including the brain, pancreas, and reproductive organs. It is a potential drug target and biomarker for various diseases.
GPR199P is a member of the GPCR family 190, which includes over 200 different genes. The GPCR gene family has a well-established genomic location on chromosome 7q34. GPR199P has four exons, which are located at positions 182-186 on the reference gene human chromosome 1 (human genome, HGU). The last exon is a splice variant, which may contribute to the variable expression of GPR199P in different tissues and cells.
GPR199P is a 12-kDa protein that consists of an extracellular domain, a transmembrane segment, and an intracellular segment. The extracellular domain is the region that interacts with the extracellular environment, including ligands and other proteins. The transmembrane segment is the region that spans the membrane of the cell and interacts with the intracellular segment. The intracellular segment is the region that interacts with other intracellular proteins.
GPR199P is involved in various physiological processes, including sensory perception, neurotransmission, and hormone signaling. It is involved in the regulation of pain perception, anxiety and depression, and reproductive function. GPR199P is also involved in the regulation of inflammation and immune responses.
GPR199P is a potential drug target for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Studies have shown that GPR199P is involved in the development and progression of cancer, including breast, ovarian, and prostate cancer. GPR199P has also been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. GPR199P has also been shown to be involved in the regulation of reproductive function, including female reproductive cycle and male sexual function.
GPR199P is also a potential biomarker for various diseases. GPR199P has also been shown to be involved in the regulation of pain perception, anxiety and depression, and reproductive function. GPR199P has also been shown to be involved in the regulation of inflammation and immune responses. These properties make GPR199P a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.
In conclusion, GPR199P is a GPCR that is expressed in many tissues and cells, including the brain, pancreas, and reproductive organs. It is a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Further research is needed to fully understand the role of GPR199P in various physiological processes and to develop effective treatments for these diseases.
Protein Name: G Protein-coupled Receptor 199, Pseudogene
The "GPR199P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPR199P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1
